Perceptive Advisors’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-37,081
| Closed | -$4.36M | – | 125 |
|
2019
Q4 | $4.36M | Hold |
37,081
| – | – | 0.09% | 80 |
|
2019
Q3 | $3.36M | Hold |
37,081
| – | – | 0.09% | 79 |
|
2019
Q2 | $2.03M | Hold |
37,081
| – | – | 0.05% | 84 |
|
2019
Q1 | $1.82M | Hold |
37,081
| – | – | 0.05% | 77 |
|
2018
Q4 | $1.48M | Buy |
+37,081
| New | +$1.48M | 0.06% | 76 |
|
2018
Q3 | – | Sell |
-4,306
| Closed | -$117K | – | 134 |
|
2018
Q2 | $117K | Buy |
4,306
+419
| +11% | +$11.4K | ﹤0.01% | 122 |
|
2018
Q1 | $190K | Hold |
3,887
| – | – | 0.01% | 124 |
|
2017
Q4 | $176K | Hold |
3,887
| – | – | 0.01% | 128 |
|
2017
Q3 | $267K | Hold |
3,887
| – | – | 0.01% | 130 |
|
2017
Q2 | $247K | Hold |
3,887
| – | – | 0.01% | 116 |
|
2017
Q1 | $254K | Hold |
3,887
| – | – | 0.01% | 128 |
|
2016
Q4 | $233K | Sell |
3,887
-1,041
| -21% | -$62.4K | 0.02% | 135 |
|
2016
Q3 | $414K | Hold |
4,928
| – | – | 0.03% | 141 |
|
2016
Q2 | $336K | Hold |
4,928
| – | – | 0.02% | 127 |
|
2016
Q1 | $360K | Hold |
4,928
| – | – | 0.03% | 135 |
|
2015
Q4 | $594K | Hold |
4,928
| – | – | 0.04% | 92 |
|
2015
Q3 | $626K | Hold |
4,928
| – | – | 0.05% | 93 |
|
2015
Q2 | $745K | Hold |
4,928
| – | – | 0.04% | 114 |
|
2015
Q1 | $1.13M | Sell |
4,928
-434
| -8% | -$99.9K | 0.09% | 92 |
|
2014
Q4 | $1.29M | Hold |
5,362
| – | – | 0.11% | 90 |
|
2014
Q3 | $1.98M | Buy |
5,362
+15
| +0.3% | +$5.55K | 0.2% | 63 |
|
2014
Q2 | $2.44M | Sell |
5,347
-631
| -11% | -$288K | 0.24% | 55 |
|
2014
Q1 | $3.3M | Sell |
5,978
-3,167
| -35% | -$1.75M | 0.35% | 51 |
|
2013
Q4 | $5.24M | Buy |
9,145
+8,823
| +2,740% | +$5.05M | 0.63% | 35 |
|
2013
Q3 | $366K | Buy |
+322
| New | +$366K | 0.03% | 65 |
|